Antitrust and Competition Law Issues in the Healthcare Industry

Antitrust and Competition Law Issues in the Healthcare Industry

Speaking Engagement CLE

Partner Hartmut Schneider will provide an overview of fundamental principles and recent developments in antitrust and competition law, with a particular focus on the healthcare industry. The seminar will begin with a review of first questions to ask in any matter with potential antitrust or competition law implications, followed by a discussion of specific antitrust/competition law considerations, including in the licensing, R&D, distribution, and pricing contexts.

WilmerHale has been accredited by the New York State and California State Continuing Legal Education Boards as a provider of continuing legal education. This program is being planned with the intention to offer CLE credit in California and non-transitional CLE credit in New York. This program, therefore, is being planned with the intention to offer CLE for experienced New York attorneys only. Attorneys in England and Wales may also claim unaccredited CPD credit for attending this program. WilmerHale is not an accredited provider of Pennsylvania CLE but we will apply for Pennsylvania CLE if requested. The type and amount of credit awarded will be determined solely by the Pennsylvania State CLE Board. New Jersey will grant reciprocal credit for programs that are approved in New York. We will issue New York Certificates of Attendance to attorneys who request New Jersey Credit. Attendees requesting CLE credit must attend the entire program.

This program will be held live in King of Prussia, PA and is available to remote participants by webinar. For additional information, please email Mary Lynn Stoffel.

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.